Target intelligence / Profile preview

Sideroflexin 5 pseudogene

Molecular classification
Pseudogene (unprocessed or processed pseudogene, depending on origin—canonical data does not specify which in this case)
01

Overview

Sideroflexin 5 pseudogene (ENSG00000271667) is a DNA sequence in the human genome with high sequence similarity to the functional Sideroflexin 5 gene, but is incapable of producing a functional protein product due to accumulated mutations or loss of regulatory elements[1][3][4]. Pseudogenes such as this arise through various genetic mechanisms, including gene duplication followed by degradation or retrotransposition of mRNA. Most pseudogenes are biologically inert and do not contribute to physiological processes, drug response, or disease except in rare cases where they act as regulatory noncoding RNAs[3][5]. There is no evidence that this specific pseudogene fulfills such a role, nor is it considered a direct therapeutic target. Its annotation is important to avoid misinterpretation in genetic and molecular assays, as pseudogenes can sometimes be amplified or sequenced alongside their functional counterparts, leading to confusion or error in experimental studies[3][4].

Other names
ENSG00000271667SFXN5P
02

Mechanism of action

None. Drugs cannot act on nonfunctional pseudogenes.

03

Biological functions

Most pseudogenes do not have biological functions; however, rare exceptions exist where pseudogene transcripts act as regulatory RNAs, but no evidence suggests this specific pseudogene (ENSG00000271667) exerts a functional role
04

Disease associations

None documented. Pseudogenes usually do not participate directly in disease pathways unless reactivated or co-opted as regulatory RNAs, which has not been reported for this target

Beyond the preview

Go deeper on Sideroflexin 5 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sideroflexin 5 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call